OrisDx

OrisDX is a saliva diagnostic startup that is transforming cancer detection and clinical decision-making through non-invasive molecular testing. Its first product — an oral rinse test for the early detection of head and neck cancers — is built on research from the University of Chicago. Headquartered in Chicago, OrisDX was the first-place winner of the 2022 University of Chicago Startup Challenge. As an alumnus of the inaugural SMILE Health program, OrisDX is committed to making a significant impact on public health.